SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BTMD

biote Corp. (NASDAQ:BTMD)

US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
$0.81-$0.03 (-3.56%)
 
Market cap
$35.9M
Insider Score
Analyst consensus
Listed since
Apr 28, 2021
Website
Market Cap$35.93M-67.8%
Revenue (ttm)n/a-8.6%
Net Incomen/a-106.7%
EPSn/a-111.2%
Shares Out44.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,778
Open$0.82
Previous Close$0.84
Day's Range$0.81 - $0.84
52-Week Range$0.81 - $2.90
Beta1.74
AnalystsBuy
Price Target$3.25(+298.92%)
Earnings Daten/a
-2.94% (1D)
No price history available.

About BTMD

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

Address
1875 West Walnut Hill Lane, Irving, TX, 75038, US
Market Cap
36 million
Employees
223
Industrial Classification
Medical - Care Facilities

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$202.20K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-3.56%
5 Days
-22.41%
1 Month
-25.26%
6 Months
-59.06%
1 Year
-67.80%

$BTMD stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BTMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BTMD's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BTMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BTMD Revenue by Segment or Geography

$57.15MTotal
Single Reporting Segment$43.33M75.82%
Employee-related costs$13.82M24.18%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BTMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BTMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BTMD

VTIVanguard Morningstar Total Stock Market ETF$597.47K
VXFVanguard Extended Market ETF$275.98K
DFASDimensional - US Small Cap ETF$189.34K
DFMCU.S. Micro Cap Portfolio ETF$105.07K
IWCiShares Micro-Cap ETF$77.63K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$30.00K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BTMD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
41.89
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
2
Sells
0
Buy Value
$202.20K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.04%

Weight is the stock’s share of each fund’s holdings.